Asthma and persistent low sputum eosinophilia

M. Latorre, E. Bacci, L. Melosini, F. Novelli, S. Cianchetti, L. Ruocco, M. L. Bartoli, F. L. Dente, A. Di Franco, P. L. Paggiaro (Pisa, Italy)

Source: Annual Congress 2009 - Airway inflammation and asthma control
Session: Airway inflammation and asthma control
Session type: Thematic Poster Session
Number: 3959
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Latorre, E. Bacci, L. Melosini, F. Novelli, S. Cianchetti, L. Ruocco, M. L. Bartoli, F. L. Dente, A. Di Franco, P. L. Paggiaro (Pisa, Italy). Asthma and persistent low sputum eosinophilia. Eur Respir J 2009; 34: Suppl. 53, 3959

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of sputum eosinophilia in severe asthma
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


Persistent sputum eosinophilia in patients with difficult-to-treat asthma
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010

Sputum eosinophilia in patients with chronic cough
Source: Eur Respir J 2007; 30: Suppl. 51, 585s
Year: 2007

IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015


Induced sputum IL-13 concentration in asthma, COPD and eosinophilic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 594s
Year: 2004

Induced sputum concentrations of mucin in patients with asthma and chronic cough
Source: Eur Respir J 2007; 30: Suppl. 51, 61s
Year: 2007

Eosinophilic inflammation in sputum of poorly controlled asthmatics
Source: Eur Respir J 2002; 20: 1370-1377
Year: 2002



Correlation between nasal secretion eosinophilia and induced sputum eosiniphilia in pediatric asthma
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010


Sputum eosinophils and bronchial hyperreactivity in patients with chronic cough
Source: Eur Respir J 2005; 26: Suppl. 49, 479s
Year: 2005

Induced sputum to assess bronchial inflammation in children with intermittent athopic asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 399s
Year: 2003

Sputum eosinophilia in the diagnosis and management of asthma of moderate severity in adults
Source: Eur Respir J 2007; 30: Suppl. 51, 587s
Year: 2007

Small airways disease and peripheral eosinophilia predict airway hyperresponsiveness in Irish patients with suspected asthma
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015

Monitoring of sputum eosinophils in long-term treatment of bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 111s
Year: 2002

Induced sputum eosinophils, bronchial reactivity and cough sensitivity in allergic rhinitis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 583s
Year: 2005

Induced sputum and airway inflammation in asthma and COPD
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006

Bronchial hyperactivity in perimenstrual asthma is higher than in non-PMA asthmatics and correlates with sputum levels of eotaxin and IL-4
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014

Bronchial responsiveness, lung function and induced sputum eosinophilia in outgrown childhood asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015


Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015